These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35852272)

  • 21. Prolonged perilesional edema after treatment of parenchymal neurocysticercosis: methotrexate as a corticosteroid-sparing agent.
    Keiser PB; Nash TE
    Clin Infect Dis; 2003 May; 36(10):e122-6. PubMed ID: 12746791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticysticercal treatment and seizures in neurocysticercosis.
    Singh G; Sander JW
    Lancet Neurol; 2004 Apr; 3(4):207-8. PubMed ID: 15039032
    [No Abstract]   [Full Text] [Related]  

  • 23. Tapeworm headache.
    University of South Alabama Headache Center
    Headache; 2004 Apr; 44(4):374. PubMed ID: 15109363
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case of neurocysticercosis presenting as focal seizure].
    Sugiyama M; Okada T; Higuchi H; Yabe Y; Kobayashi N; Teramoto A
    No Shinkei Geka; 2000 Sep; 28(9):807-10. PubMed ID: 11025881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurocysticercosis: an update.
    Carpio A
    Lancet Infect Dis; 2002 Dec; 2(12):751-62. PubMed ID: 12467692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.
    Jung-Cook H
    Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of medical treatment of neurocysticercosis: a study of 65 cases in Cheju Island, Korea.
    Kim SK; Wang KC; Paek SH; Hong KS; Cho BK
    Surg Neurol; 1999 Dec; 52(6):563-9. PubMed ID: 10660021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis.
    Arroyo G; Bustos JA; Lescano AG; Gonzales I; Saavedra H; Rodriguez S; Pretell EJ; Bonato PS; Lanchote VL; Takayanagui OM; Horton J; Gonzalez AE; Gilman RH; Garcia HH;
    Clin Infect Dis; 2019 Nov; 69(11):1996-2002. PubMed ID: 30715265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neurocysticercosis: report of three cases and recommendations of treatment].
    Alvarez Rodríguez E; Torres-Gárate R; Gutiérrez Larráinzar A; Cabello J; Espinós Pérez D
    An Med Interna; 2004 Aug; 21(8):382-6. PubMed ID: 15373721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: an 8 year randomised study.
    Das K; Mondal GP; Banerjee M; Mukherjee BB; Singh OP
    J Clin Neurosci; 2007 Dec; 14(12):1172-7. PubMed ID: 17964789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug treatment of neurocysticercosis.
    Garg RK
    Natl Med J India; 1997; 10(4):173-7. PubMed ID: 9325640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the course of neurocysticercosis modified by treatment with antihelminthic agents?
    Carpio A; Santillán F; León P; Flores C; Hauser WA
    Arch Intern Med; 1995 Oct; 155(18):1982-8. PubMed ID: 7575052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurocysticercosis: an unusual cause of seizure in the New Zealand setting.
    Pybus M; Heron P
    J Paediatr Child Health; 2012 Mar; 48(3):E119-21. PubMed ID: 21276113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Be careful while using albendazole/praziquantel in neurocysticercosis.
    Garg RK; Uniyal R; Malhotra HS
    Neurol India; 2017; 65(4):924-926. PubMed ID: 28681797
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of Combination Therapy of Albendazole and Praziquantel vs Albendazole Monotherapy in Children With Persistent Neurocysticercosis: A Randomized Controlled Trial.
    Singh K; Saini AG; Khandelwal N; Singhi P
    J Child Neurol; 2022 Apr; 37(5):366-372. PubMed ID: 35213246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurocysticercosis an uncommon intra-cerebral infection in Malaysia.
    Arasu K; Khairul A; Waran V
    Med J Malaysia; 2005 Oct; 60(4):514-6. PubMed ID: 16570721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical management of neurocysticercosis.
    Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
    Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Ivermectin in Neurocysticercosis: A Case Report.
    Samannodi MS; Zhao A; Hasbun R
    Am J Case Rep; 2018 Nov; 19():1378-1381. PubMed ID: 30455413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of imported neurocysticercosis in Portugal.
    Valadas E; Badura R; Marques T; Neno M; Boura M; Sutre AF; Beato S; Grácio MA; Neves JC
    J Infect Dev Ctries; 2015 Jan; 9(1):114-7. PubMed ID: 25596581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical analysis of 52 cases of neurocysticercosis.
    Chaoshuang L; Zhixin Z; Xiaohong W; Zhanlian H; Zhiliang G
    Trop Doct; 2008 Jul; 38(3):192-4. PubMed ID: 18628562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.